HP and Parkinson disease: Interestingly, Parkinson’s disease has been associated with markers of intestinal permeability (e.g., orally administered sugar probes and fecal zonulin), inflammation (e.g., fecal calprotectin), and a dysregulated microbiota that may impact disease progression [3,15,16,17].